Compounds > pyrilamine
Page last updated: 2024-08-16

pyrilamine and tamoxifen

pyrilamine has been researched along with tamoxifen in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrews, PR; Craik, DJ; Martin, JL1
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Marshall, K; Senior, J1
Bogdanovic, RP; Brandes, LJ1
Brandes, LJ; Kroeger, EA1

Other Studies

7 other study(ies) available for pyrilamine and tamoxifen

ArticleYear
Functional group contributions to drug-receptor interactions.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:12

    Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship

1984
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
    Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2

    Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase

2008
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
The effect of mepyramine and ranitidine on the oestrogen and anti-oestrogen stimulated rat uterus.
    British journal of pharmacology, 1986, Volume: 89, Issue:1

    Topics: Aminopyridines; Animals; Estrogen Antagonists; Estrogens; Female; Organ Size; Pyrilamine; Ranitidine; Rats; Receptors, Histamine; Regional Blood Flow; Tamoxifen; Uterine Contraction; Uterus

1986
New evidence that the antiestrogen binding site may be a novel growth-promoting histamine receptor (?H3) which mediates the antiestrogenic and antiproliferative effects of tamoxifen.
    Biochemical and biophysical research communications, 1986, Jan-29, Volume: 134, Issue:2

    Topics: Animals; Binding, Competitive; Biological Assay; Cimetidine; Female; Hydroxyzine; Microsomes, Liver; Ovariectomy; Phosphatidylethanolamines; Pyrilamine; Rats; Receptors, Estrogen; Receptors, Histamine; Structure-Activity Relationship; Tamoxifen; Uterus

1986
Evidence that tamoxifen is a histamine antagonist.
    Biochemical and biophysical research communications, 1985, Sep-16, Volume: 131, Issue:2

    Topics: Acetylcholine; Animals; Dogs; Female; Histamine; Histamine Antagonists; Hydroxyzine; Male; Muscle Contraction; Phosphatidylethanolamines; Potassium; Pyrilamine; Serotonin; Tamoxifen; Trachea

1985